Please login to the form below

Not currently logged in
Email:
Password:

cardiovascular disease

This page shows the latest cardiovascular disease news and features for those working in and with pharma, biotech and healthcare.

J&J’s Invokana first SGLT2 to show kidney disease benefits

J&J’s Invokana first SGLT2 to show kidney disease benefits

study,” said James List, Global Therapeutic Area Head, Cardiovascular &Metabolism, Janssen Research &Development. ... It seems likely that the other drugs in the class will also prove their value in kidney disease - just as protection against heart

Latest news

More from news
Approximately 15 fully matching, plus 231 partially matching documents found.

Latest Intelligence

  • New models of NHS care – new models of pharma response? New models of NHS care – new models of pharma response?

    The region is now adopting population health models for musculoskeletal (MSK) respiratory disease, diabetes and cardiovascular disease. ... Echoing James Roach’s sentiment, she said: “Please don't wait to be asked, but make sure you're coming to us

  • The threat of antimicrobial resistance The threat of antimicrobial resistance

    the low commercial value placed on antibiotic drugs compared to more lucrative sectors such as cardiovascular disease and cancer. ... By January 2018, the US Centers for Disease Control and Prevention had reported 29 cases of MCR resistance identified

  • Pharma deals continue to slide Pharma deals continue to slide

    J) and Xoma has licensed its interleukin 1 beta intellectual property for cardiovascular disease to Novartis plus a developed product where development had stopped. ... Gevokizumab plus IP for use of IL-1 beta targeting antibodies for cardiovascular

  • Perfecting the pharmaceutical pipeline with AI Perfecting the pharmaceutical pipeline with AI

    keeps timelines long and expensive.  This has a knock-on effect for research around rare disease types specifically.  Financial cost and ROI remain big factors for pharmaceutical companies in determining what ... For example, a drug being used for

  • The EarthWorks: New ways to improve patient care The EarthWorks: New ways to improve patient care

    Keeping people well and preventing illness. Technology is only interesting socially when it is boring technologically; we have to have scale to begin to prevent disease on a population level. ... cardiovascular disease and transplantation.

More from intelligence
Approximately 0 fully matching, plus 21 partially matching documents found.

Latest appointments

  • Sanifit appoints Alexander Gold chief medical officer Sanifit appoints Alexander Gold chief medical officer

    Alex arrives here with first class operational and clinical development expertise in novel drug therapies, targeting cardiovascular and metabolic disease and kidney disease amongst others.

  • Leading Edge bolsters its delivery team Leading Edge bolsters its delivery team

    Francesca Worthington joins the group as an account manager after working across a variety of medical communication programmes and in a number of therapy areas, including haematology, ophthalmology, cardiovascular disease and

  • MyoKardia appoints COO and medical affairs VP MyoKardia appoints COO and medical affairs VP

    Prior to this, Dr Lee was therapeutic area head for cardiovascular, metabolic, respiratory and infectious disease programmes at Genentech. ... Their expertise and counsel will broaden our base of leadership and support our mission to change the world for

  • The Medicines Company appoints Biogen's Tony Kingsley The Medicines Company appoints Biogen's Tony Kingsley

    He will also serve at the company, which focuses on serious infectious disease care, acute cardiovascular care, and surgery and perioperative care, as its president, taking over from Glenn Sblendorio, who

  • MedImmune appoints Dr Christopher Rhodes MedImmune appoints Dr Christopher Rhodes

    Will head cardiovascular and metabolic diseaseresearch for the AZ unit. AstraZeneca's biologics research and development arm MedImmune has appointed Dr Christopher Rhodes as vice president, cardiovascular and metabolic disease (CVMD) ... exciting time

More from appointments
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest from PMHub

  • emotive adds to medical team with new Scientific Lead and Associate Medical Writer

    in rare diseases such as Gaucher disease and Cushing’s disease and in hepatitis C. She also has experience in cardiovascular disease, haematology and infectious diseases. ... emotive is an award-winning healthcare communications agency working

  • Barber shops provide a short cut to BP reduction

    The basics of preventive medicine are cut and dried: don't smoke, eat less, drink less, exercise more, and reduce your risk factors for life-limiting illnesses like cardiovascular disease, diabetes ... Men are particularly reluctant to visit their doctor

  • IGNIFI

    cardiovascular disease . diabetes. women’s health . nutrition . allergy . infectious diseases . wound care .

  • ECHO Medical Communications

    ECHO delivers dedicated medical communications specialising in the areas of endocrinology, cardiovascular disease, heart failure and obesity.

  • ECHO Medical Communications

    ECHO delivers dedicated medical communications specialising in the areas of endocrinology, cardiovascular disease, heart failure and obesity.

More from PMHub
Approximately 0 fully matching, plus 14 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Random42 Scientific Communication

Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics